LLY

1,019.18

+2.96%↑

JNJ

230.3

+2.26%↑

ABBV

208.61

+0.24%↑

UNH

401.79

+1.9%↑

AZN

186.75

+0.93%↑

LLY

1,019.18

+2.96%↑

JNJ

230.3

+2.26%↑

ABBV

208.61

+0.24%↑

UNH

401.79

+1.9%↑

AZN

186.75

+0.93%↑

LLY

1,019.18

+2.96%↑

JNJ

230.3

+2.26%↑

ABBV

208.61

+0.24%↑

UNH

401.79

+1.9%↑

AZN

186.75

+0.93%↑

LLY

1,019.18

+2.96%↑

JNJ

230.3

+2.26%↑

ABBV

208.61

+0.24%↑

UNH

401.79

+1.9%↑

AZN

186.75

+0.93%↑

LLY

1,019.18

+2.96%↑

JNJ

230.3

+2.26%↑

ABBV

208.61

+0.24%↑

UNH

401.79

+1.9%↑

AZN

186.75

+0.93%↑

Home・Stock List・Medpace Holdings Inc

Medpace Holdings Inc

Open

SectorHealthcare

421.58 0.48

Buy Sell

Overview

Share price change

24h

Current

Min

411.69

Max

422.51

Key metrics
By Trading Economics
Income	-11M 124M
Sales	-1.8M 707M
P/E Sector Avg	26.245 51.415
EPS	4.28
Profit margin	17.53
Employees	6,300
EBITDA	-16M 148M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+10.24% upside

Dividends
By Dow Jones
Next Earnings	20 Jul 2026

Market Stats
By TradingEconomics
Market Cap	-3.2B 12B
Previous open	421.1
Previous close	421.58

News Sentiment

By Acuity

76%

24%

319 / 346 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

300 / 302.88 Support & Resistance

Medpace Holdings Inc Chart

Past performance is not a reliable indicator of future results.

Related News

23 Oct 2025, 15:15 UTC

Earnings

Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back -- Barrons.com

Peer Comparison

Price change

Medpace Holdings Inc Forecast

Price Target

By TipRanks

10.24% upside

12 Months Forecast

Average 460 USD 10.24%

High 560 USD

Low 393 USD

Based on 9 Wall Street analysts offering 12 month price targets forMedpace Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

9 ratings

Buy

Hold

Sell

Based on 9 analysts giving stock ratings to Medpace Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

300 / 302.88Support & Resistance

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

319 / 346 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.